Rhabdomyolysis associated with the nutritional supplement Hydroxycut

American Journal of Health-System Pharmacy

Volumn 66, Issue 2, 2009, Pages 142-148

  Dehoney, Sarah ^a   Wellein, Marlea ^b  

^a UNIVERSITY OF UTAH   (United States)

^b Trident Medical Center   (United States)

Author keywords

Acetaminophen; Amphetamines; Cyclobenzaprine; Dextroamphetamine saccharate; Dietary supplements; Hydrocodone; Naproxen sodium; Rhabdomyolysis; Toxicity

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMPHETAMINE; ASPARTATE AMINOTRANSFERASE; CAFFEINE; CALCIUM SALT; CATECHIN; CHROMIUM; CISSUS QUADRANGULARIS EXTRACT; CODONOPSIS PILOSULA EXTRACT; CREATINE; CREATINE KINASE; CYCLOBENZAPRINE; DEANOL; EVODIA FRUIT EXTRACT; GARCINIA CAMBOGIA EXTRACT; GREEN TEA EXTRACT; GYMNEMA SYLVESTRE EXTRACT; HYDROCODONE BITARTRATE PLUS PARACETAMOL; NAPROXEN; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PHYTIC ACID; POTASSIUM SALT; RHODIOLA ROSEA EXTRACT; SODIUM CHLORIDE; TROXERUTIN; UNINDEXED DRUG; WITHANIA SOMNIFERA EXTRACT; XANTHINOL NICOTINATE;

ADULT; ARTICLE; CASE REPORT; CISSUS QUADRANGULARIS; DIET SUPPLEMENTATION; EPHEDRA; EXERCISE; GARCINIA; GYMNEMA; HUMAN; HYDRATION; MALE; PRIORITY JOURNAL; RHABDOMYOLYSIS; TEA; WEIGHT REDUCTION; WILLOW; WITHANIA;

EID: 58449085449     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.2146/ajhp070640     Document Type: Article

References (46)

1. National Center for Complementary and Alternative Medicine. The use of complementary and alternative medicine in the United States, http://nccam.nih.gov/ news/camsurvey-fs1.htm (accessed 2007 Jul 16).
2. Food and Drug Administration. The facts about weight loss products and programs. www.cfsan.fda.gov/~dms/ wgtloss.html (accessed 2007 Jul 16).
3. Scroggie DA, Harris M, Sakai L. Rhabdomyolysis associated with nutritional supplement use. J Clin Rheumatol. 2000; 6:328-32.
4. Sandhu RS, Como JJ, Scalea TS et al. Renal failure and exercise-induced rhabdomyolysis in patients taking performance-enhancing compounds. J Trauma. 2002; 53:761-4.
5. Mansi IA, Huang J. Rhabdomyolysis in response to weight-loss herbal medicine. Am J Med Sci. 2004; 327:356-7. [Erratum, Am J Med Sci. 2004; 328:129.]
6. Stahl CE, Borlongan CV, Szerlip H et al. No pain, no gain - exercise-induced rhabdomyolysis associated with the performance enhancer herbal supplement ephedra. Med Sci Monit. 2006; 12:CS81-4.
7. Robinson SJ. Acute quadriceps compartment syndrome and rhabdomyolysis in a weight lifter using high-dose creatine supplementation. J Am Board Fam Pract. 2000; 13:134-7.
8. Sheth NP, Sennett B, Berns JS. Rhabdomyolysis and acute renal failure following arthroscopic knee surgery in a college football player taking creatine supplements. Clin Nephrol. 2006; 65:134-7.
9. Do KD, Bellabarba C, Bhananker SM. Exertional rhabdomyolysis in a bodybuilder following overexertion: a possible link to creatine overconsumption. Clin J Sport Med. 2007; 17:78-9.
10. Kamijo Y, Soma K, Asari Y et al. Severe rhabdomyolysis following massive ingestion of oolong tea: caffeine intoxication with coexisting hyponatremia. Vet Hum Toxicol. 1999; 41:381-3.
11. Wrenn KD, Oschner I. Rhabdomyolysis induced by a caffeine overdose. Ann Emerg Med. 1989; 18:94-7.
12. Huerta-Alardin AL, Varon J, Marik PE. Bench-to-bedside review: rhabdomyolysis - an overview for clinicians. Crit Care. 2005; 9:158-69.
13. Sinert R, Kohl L, Rainone T et al. Exercise-induced rhabdomyolysis. Ann Emerg Med. 1994; 23:1301-6.
14. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. 2003; 289:1681-90.
15. Vanholder R, Sever MS, Erek E et al. Rhabdomyolysis. J Am Soc Nephrol. 2000; 11:1553-61.
16. Sauret JM, Marinides G, Wang GK. Rhabdomyolysis. Am Fam Physician. 2002; 65:907-12.
17. National Center for Complementary and Alternative Medicine. Ephedra consumer advisory. http://nccam.nih.gov/health/ alerts/ephedra/consumer advisory.htm (accessed 2007 Jul 16).
18. Martin WR, Fuller RE. Suspected chromium picolinate-induced rhabdomyolysis. Pharmacotherapy. 1998; 18:860-2.
19. Hydroxycut supplement facts, www. hydroxycut.com/products (accessed 2008 Oct 25).
20. MuscleTech. Hydroxycut Hardcore facts. www.muscletech.com/products/ hydroxycut-hardcore/index.shtml (accessed 2008 Nov 3).
21. Grover DS, Atta MG, Eustace JA et al. Lack of clinical utility of urine myoglobin detection by microconcentrator ultrafiltration in the diagnosis of rhabdomyolysis. Nephrol Dial Transplant. 2004; 19:2634-8.
22. Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med. 2005; 142:477-8.
23. Kockler DR, McCarthy MW, Lawson CL. Seizure activity and unresponsiveness after hydroxycut ingestion. Pharmacotherapy. 2001; 21:647-51.
24. Naranjo CA, Busto U, Sellers EM et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981; 30:239-45.
25. Pharmacist's Letter/Prescriber's Letter Natural Medicines Comprehensive Database. www.naturaldatabase.com (accessed 2007 Jun 10).
26. Zemel MB. Regulation of adiposity and obesity risk by dietary calcium: mechanisms and implications. J Am Coll Nutr. 2002; 21:146S-151S.
27. Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998; 56:266-70.
28. Lowenstein JM. Effect of (-)-hydroxycitrate on fatty acid synthesis by rat liver in vivo. J Biol Chem. 1971; 246: 629-32.
29. Heymsfield SB, Allison DB, Vasselli JR et al. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998; 280:1596-600.
30. Yeh GY, Eisenberg DM, Kaptchuk TJ et al. Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care. 2003; 26:1277-94.
31. DerMarderosian A, Beutler JA, eds. The review of natural products. 3rd ed. St. Louis: Facts and Comparisons; 2008.
32. Dulloo AG, Duret C, Rohrer D et al. Efficacy of a green tea extract rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat oxidation in humans. Am J Clin Nutr. 1999; 70:1040-5.
33. Acheson KJ, Gremaud G, Meirim I et al. Metabolic effects of caffeine in humans: lipid oxidation or futile cycling? Am J Clin Nutr. 2004; 79:40-6.
34. Westerterp-Plantenga M, Diepvens K, Joosen AM et al. Metabolic effects of spices, teas, and caffeine. Physiol Behav. 2006; 89:85-91.
35. Oben JE, Enyegue DM, Fomekong GI et al. The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress. Lipids Health Dis. 2007; 6:4.
36. Horton TJ, Geissler CA. Aspirin potentiates the effect of ephedrine on the thermogenic response to a meal in obese but not lean women. Int J Obes. 1991; 15:359-66.
37. Dulloo AG, Miller DS. Aspirin as a promoter of ephedrine-induced thermogenesis: potential use in the treatment of obesity. Am J Clin Nutr. 1987; 45:564-9.
38. Pieralisi G, Ripari P, Vecchiet L. Effects of a standardized ginseng extract combined with dimethylaminoethanol bitartrate, vitamins, minerals, and trace elements on physical performance during exercise. Clin Ther. 1991; 13:373-82.
39. Kobayashi Y, Nakano Y, Kizaki M et al. Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Med. 2001; 67:628-33.
40. Leung AY, Foster S. Encyclopedia of common natural products used in food, drugs, and cosmetics. 2nd ed. New York: Wiley; 1996:185-6.
41. Tietjen DP, Guzzi LM. Exertional rhabdomyolysis and acute renal failure following the Army Physical Fitness Test. Mil Med. 1989; 154:23-5.
42. Clarkson P. Exertional rhabdomyolysis and acute renal failure in marathon runners. Sports Med. 2007; 37:361-3.
43. Daher Ede F, Silva Júnior GB, Brunetta DM et al. Rhabdomyolysis and acute renal failure after strenuous exercise and alcohol abuse: case report and literature review. Sao Paulo Med J. 2005; 123:33-7.
44. Adderall XR package insert. Wayne, PA: Shire US Inc.; 2007 Mar.
45. Drugdex database. Greenwood Village, CO: Thomson Micromedex.
46. Food and Drug Administration. Letter to stakeholders: announcing CAERS - the CFSAN Adverse Event Reporting System. www.cfsan.fda.gov/~dms/caersltr.html (accessed 2007 Jun 3).